Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX

NCT03975790 · clinicaltrials.gov ↗
COMPLETED
Status
479
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer